A nucleotidyltransferase toxin inhibits growth of <i>Mycobacterium tuberculosis</i> through inactivation of tRNA acceptor stems.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32923609.
- Also identified by DOI 10.1126/sciadv.abb6651 and PMC identifier 7450476.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Toxin-antitoxin systems are widespread stress-responsive elements, many of whose functions remain largely unknown. Here, we characterize the four DUF1814-family nucleotidyltransferase-like toxins (MenT<sub>1-4</sub>) encoded by the human pathogen <i>Mycobacterium tuberculosis</i>. Toxin MenT<sub>3</sub> inhibited growth of <i>M. tuberculosis</i> when not antagonized by its cognate antitoxin, MenA<sub>3</sub>. We solved the structures of toxins MenT<sub>3</sub> and MenT<sub>4</sub> to 1.6 and 1.2 Å resolution, respectively, and identified the biochemical activity and target of MenT<sub>3</sub>. MenT<sub>3</sub> blocked in vitro protein expression and prevented tRNA charging in vivo. MenT<sub>3</sub> added pyrimidines (C or U) to the 3'-CCA acceptor stems of uncharged tRNAs and exhibited strong substrate specificity in vitro, preferentially targeting tRNA<sup>Ser</sup> from among the 45 <i>M</i>. <i>tuberculosis</i> tRNAs. Our study identifies a previously unknown mechanism that expands the range of enzymatic activities used by bacterial toxins, uncovering a new way to block protein synthesis and potentially treat tuberculosis and other infections.
Medical subject headings
- Mycobacterium tuberculosis
- Toxin-Antitoxin Systems
- Tuberculosis